There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cooper Co (NYSE:COO) and Spark Therapeutics (NASDAQ:ONCE) with bullish sentiments.
Cooper Co (COO)
Raymond James analyst Michael Gibbs maintained a Buy rating on Cooper Co today and set a price target of $300. The company’s shares closed yesterday at $267.56, close to its 52-week high of $269.31.
Gibbs has an average return of 12.9% when recommending Cooper Co.
According to TipRanks.com, Gibbs is ranked #572 out of 4879 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cooper Co with a $285.60 average price target.
See today’s analyst top recommended stocks >>
Spark Therapeutics (ONCE)
In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on Spark Therapeutics, with a price target of $103. The company’s shares closed yesterday at $57.18.
Piros observed:
“We rate Spark Therapeutics Overweight. ONCE focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. With lead candidate LUXTURNA, Spark has become the first company in the U.S. with an approval for an in-vivo gene therapy product. 12-month price target is determined by the sum of the risk-adjusted NPV for the after-tax and discounted value of the programs analyzed, a platform value for the remaining pipeline and YE19 cash.”
According to TipRanks.com, Piros has 0 stars on 0-5 star ranking scale with an average return of -2.8% and a 50.0% success rate. Piros covers the Healthcare sector, focusing on stocks such as Spring Bank Pharmaceuticals Inc, Strongbridge Biopharma Plc, and Global Blood Therapeutics.
Spark Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $71.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ONCE:
